These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20355153)

  • 21. Detection of prohibited substances by liquid chromatography tandem mass spectrometry for sports doping control.
    Ahrens BD; Starcevic B; Butch AW
    Methods Mol Biol; 2012; 902():115-28. PubMed ID: 22767112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annual banned-substance review-Analytical approaches in human sports drug testing 2021/2022.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2023 Jan; 15(1):5-26. PubMed ID: 36369629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The analytical chemistry of drug monitoring in athletes.
    Bowers LD
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Thomas A; Wachsmuth P; Orlovius AK; Sigmund G; Thevis M; Schänzer W
    J Pharm Biomed Anal; 2016 Nov; 131():482-496. PubMed ID: 27693991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges and perspectives in anti-doping testing.
    Schamasch P; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M; Schänzer W
    Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
    Van Eenoo P; Delbeke FT
    J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):161-78. PubMed ID: 17000101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The list of prohibited substances and methods in sport: structure and review process by the world anti-doping agency.
    Mazzoni I; Barroso O; Rabin O
    J Anal Toxicol; 2011 Nov; 35(9):608-12. PubMed ID: 22080899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and Development of the List of Prohibited Substances and Methods.
    Kinahan A; Budgett R; Mazzoni I
    Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoisomers in sports drug testing: Analytical strategies and applications.
    Thomas A; Thevis M
    J Chromatogr A; 2022 Jul; 1674():463154. PubMed ID: 35613502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sport-Specific Use of Doping Substances: Analysis of World Anti-Doping Agency Doping Control Tests between 2014 and 2017.
    Aguilar-Navarro M; Salinero JJ; Muñoz-Guerra J; Plata MDM; Del Coso J
    Subst Use Misuse; 2020; 55(8):1361-1369. PubMed ID: 32186429
    [No Abstract]   [Full Text] [Related]  

  • 33. Current role of LC-MS(/MS) in doping control.
    Thevis M; Thomas A; Schänzer W
    Anal Bioanal Chem; 2011 Aug; 401(2):405-20. PubMed ID: 21424519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of emerging patterns of drug misuse in sports via wastewater monitoring: A mini-review and potential strategies.
    Chang WC; Hsu MC; Liao PC
    Environ Pollut; 2023 Sep; 333():122087. PubMed ID: 37348696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent advances in the detection of human erythropoietin and human growth hormone doping].
    Guo L; Zhang Z; Tang J; Xie J
    Se Pu; 2008 Jul; 26(4):437-43. PubMed ID: 18959238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.
    Thevis M; Schänzer W
    Rapid Commun Mass Spectrom; 2016 Mar; 30(5):635-51. PubMed ID: 26842585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generic sample preparation and dual polarity liquid chromatography-time-of-flight mass spectrometry for high-throughput screening in doping analysis.
    Kolmonen M; Leinonen A; Kuuranne T; Pelander A; Ojanperä I
    Drug Test Anal; 2009 Jun; 1(6):250-66. PubMed ID: 20355204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-drug interaction and doping, part 2: an in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of stanozolol.
    Mazzarino M; de la Torre X; Fiacco I; Botrè F
    Drug Test Anal; 2014 Oct; 6(10):969-77. PubMed ID: 24535830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary supplements containing prohibited substances.
    van der Bijl P; Tutelyan VA
    Vopr Pitan; 2013; 82(6):6-13. PubMed ID: 24741950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the use of stimulants in out-of-competition sport samples.
    Boghosian T; Mazzoni I; Barroso O; Rabin O
    J Anal Toxicol; 2011 Nov; 35(9):613-6. PubMed ID: 22080900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.